propan-2-yl N-[(5S,6S)-5-(hydroxycarbamoyl)-6-(4-phenyl-3,6-dihydro-2H-pyridine-1-carbonyl)piperidin-3-yl]-N-methylcarbamate

InChIKey	`VLUAXQQDRZDFOF-YPJRHXLCSA-N`
Compound Name	propan-2-yl N-[(5S,6S)-5-(hydroxycarbamoyl)-6-(4-phenyl-3,6-dihydro-2H-pyridine-1-carbonyl)piperidin-3-yl]-N-methylcarbamate
Canonical SMILES	`CC(C)OC(=O)N(C)C1CN[C@H](C(=O)N2CC=C(c3ccccc3)CC2)[C@@H](C(=O)NO)C1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	8.19
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P04626	ERBB2	Homo sapiens	Human	PF00757 PF14843 PF07714 PF01030 PF21314	8.3	pIC50	TTD_MultiTarget
P08253	MMP2	Homo sapiens	Human	PF00040 PF00045 PF00413	8.3	pIC50	TTD_MultiTarget
O14672	ADAM10	Homo sapiens	Human	PF21299 PF00200 PF13574	8.0	IC50	ChEMBL;BindingDB